Monday, 16 September 2019

Drug Discovery News

  • Merck alzheimer's trial is a success

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2013

    Singapore: Merck, which is known as MSD outside the US and Canada, revealed positive results from its phase Ib study showing a dose-dependent decrease in ß amyloid levels in cerebral spi...Read more

  • Viralytics multi-cancer drug shows +ve results

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Apr, 2013

    Singapore: Viralytics has finalized the clinical study report on the phase I evaluation of Cavatak, which is administered intravenously to late stage melanoma, prostate, breast or colorecta...Read more

  • Forest to acquire rights to Merck's Saphris

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Dec, 2013

    Singapore: US based Forest Laboratories plans to acquire exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia ...Read more

  • FDA approves GSK meningococcal vaccine

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

    Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (meningococcal groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine). Me...Read more

  • Patrys gets 2nd Aus patent for cancer drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2013

    Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted a second Australian patent for clinical anti-cancer product PAT-SM6. The Australian Patent Offic...Read more

  • BMS to develop novel therapies for Parkinsons' disease

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Sep, 2012

    Singapore: Vanderbilt University, US, and Bristol-Myers Squibb signed a collaboration agreement for the R&D and commercialization of novel therapies acting on the mGluR4 glutamate recep...Read more

  • Glenmark receives two ANDA approvals from the FDA

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Mar, 2016

    Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food and Drug Administration (US FDA) for Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg/0...Read more

  • Researchers working on new drug for Lupus

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 20 Jul, 2012

    Singapore: It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year old, Benlysta (belimumab) is the first human monoclonal antibody for t...Read more

  • Stem cell therapy effective in liver cirrhosis

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jul, 2012

    Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chinese hospitals, documents the effectiveness of cord blood-derived stem c...Read more

  • Old drug gives hope for new treatment in autism

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    Singapore: Autism results from abnormal cell communication. Testing a new theory, researchers at the University of California, San Diego School of Medicine, have used a newly discovered fun...Read more

  • Boehringer, Swiss institute collaborate on diabetes and obesity research

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Sep, 2012

    Singapore: Boehringer Ingelheim and the Institute of Molecular Health Science and the Institute of Food, Nutrition and Health of ETH Zurich entered into a four-year, industry-academia colla...Read more

  • Omega-3 can reduce brain problems after stroke

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Feb, 2013

    Singapore: A new study by researchers at Columbia University Medical Center, US, revealed that injection of triglyceride lipid emulsions (that are rich in an omega-3 fatty acid) within a fe...Read more

  • KHK advances DsiRNA cancer target, pays $5 mn

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2013

    Singapore: Dicerna Pharmaceuticals, a RNA interference (RNAi) company focused on developing breakthrough oncology therapeutics, announced that Kyowa Hakko Kirin (KHK) has elected to advanc...Read more

  • Celgene halts phase III trial of cancer drug Revlimid

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

    Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open-label, phase III ORIGIN trial, which enrolled 450 patients in over 1...Read more

  • BMS seeks Hep C therapy approval in Japan

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

    Singapore: Bristol-Myers Squibb has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices Agency seeking the world's first interferon-free and ribavirin-free ...Read more

  • Daiichi US appoints Glenn Gormley as chairman

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2013

    Singapore: Daiichi Sankyo has appointed Dr Glenn Gormley, as president and chairman of Daiichi Sankyo, US. Dr Gormley will also continue in his existing roles as president, Daiichi Sankyo ...Read more

  • Singapore nod for BMS, Pfizer heart drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Nov, 2013

    Singapore: Health Sciences Authority (HSA) in Singapore has approved new treatment, apixaban (Eliquis), marketed by pharmaceutical companies Pfizer and Bristol-Myers Squibb (BMS), to reduce...Read more

  • Aus firm to raise $10 mn for multiple sclerosis drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Nov, 2013

    Singapore: Australia medical biotechnology company, Innate Immunotherapeutics, plans to raise up to $10.93 million (A$12) million through an IPO of up to 60 million shares at $0.18 (A$0.20)...Read more



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls